Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) announced that it has today presented new preclinical data demonstrating in vivo efficacy of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE